Literature DB >> 7324802

Plasma bile acid levels and liver disease.

I Magyar, H G Loi, T Fehér.   

Abstract

The plasma cholic acid, chenodesoxycholic acid and desoxycholic acid levels were studied by spectrofluoremetry in 153 cases. The values of 67 controls with no evidence of hepatobiliary or intestinal disease were compared with those of 86 patients with liver and biliary tract disease. The fasting values failed to provide more diagnostic information than did conventional laboratory assays. Plasma bile acid concentrations exceeding 2.5 mu mol/l are conclusive of liver or biliary disease. A cholic acid/chenodesoxycholic acid quotient higher than 1.0 is a sign of cholestasis. Estimation of bile acids after food intake was found more informative. The plasma cholic acid- and chenodesoxycholic acid levels underwent a considerable increase 1 to 2 hours after meals. A more marked increase of chenodesoxycholic acid than of cholic acid (the ratio of the two being in excess of 1.0) is indicative of cholestasis and is most marked in primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7324802

Source DB:  PubMed          Journal:  Acta Med Acad Sci Hung        ISSN: 0001-5989


  5 in total

Review 1.  Itch mechanisms and circuits.

Authors:  Liang Han; Xinzhong Dong
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

2.  The TGR5 receptor mediates bile acid-induced itch and analgesia.

Authors:  Farzad Alemi; Edwin Kwon; Daniel P Poole; TinaMarie Lieu; Victoria Lyo; Fiore Cattaruzza; Ferda Cevikbas; Martin Steinhoff; Romina Nassini; Serena Materazzi; Raquel Guerrero-Alba; Eduardo Valdez-Morales; Graeme S Cottrell; Kristina Schoonjans; Pierangelo Geppetti; Stephen J Vanner; Nigel W Bunnett; Carlos U Corvera
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

3.  The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.

Authors:  TinaMarie Lieu; Gihan Jayaweera; Peishen Zhao; Daniel P Poole; Dane Jensen; Megan Grace; Peter McIntyre; Romke Bron; Yvette M Wilson; Matteus Krappitz; Silke Haerteis; Christoph Korbmacher; Martin S Steinhoff; Romina Nassini; Serena Materazzi; Pierangelo Geppetti; Carlos U Corvera; Nigel W Bunnett
Journal:  Gastroenterology       Date:  2014-09-03       Impact factor: 22.682

4.  Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity.

Authors:  MaryPeace McRae; Naser L Rezk; Arlene S Bridges; Amanda H Corbett; Hsiao-Chuan Tien; Kim L R Brouwer; Angela D M Kashuba
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

5.  Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population.

Authors:  Munirah Alsaleh; Thomas A Barbera; Helen L Reeves; Matthew E Cramp; Stephen Ryder; Hani Gabra; Kathryn Nash; Yi-Liang Shen; Elaine Holmes; Roger Williams; Simon D Taylor-Robinson
Journal:  Hepat Med       Date:  2019-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.